Recent research indicates that Retatrutide, specifically the 40mg strength, could provide a promising advance in the treatment of obesity . Unlike many available therapies, Retatrutide functions as a double GIP and GLP-1 agent agonist, potentially resulting in greater weight loss and linked metabol